These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25747438)

  • 1. In silico identification of irreversible cathepsin B inhibitors as anti- cancer agents: virtual screening, covalent docking analysis and molecular dynamics simulations.
    Sbongile M; Soliman ME
    Comb Chem High Throughput Screen; 2015; 18(4):399-410. PubMed ID: 25747438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational analysis of the cathepsin B inhibitors activities through LR-MMPBSA binding affinity calculation based on docked complex.
    Zhou Z; Wang Y; Bryant SH
    J Comput Chem; 2009 Nov; 30(14):2165-75. PubMed ID: 19242965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of covalent enzyme inhibitors using virtual docking of covalent fragments.
    Chowdhury SR; Kennedy S; Zhu K; Mishra R; Chuong P; Nguyen AU; Kathman SG; Statsyuk AV
    Bioorg Med Chem Lett; 2019 Jan; 29(1):36-39. PubMed ID: 30455147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Novel Cathepsin B Inhibitors with Implications in Alzheimer's Disease: Computational Refining and Biochemical Evaluation.
    Chitranshi N; Kumar A; Sheriff S; Gupta V; Godinez A; Saks D; Sarkar S; Shen T; Mirzaei M; Basavarajappa D; Abyadeh M; Singh SK; Dua K; Zhang KYJ; Graham SL; Gupta V
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Potential Inhibitors of Cathepsin-B using Shape & Pharmacophore-based Virtual Screening, Molecular Docking and Explicit Water Thermodynamics.
    Sharma T; Harioudh MK; Kuldeep J; Kumar S; Banerjee D; Ghosh JK; Siddiqi MI
    Mol Inform; 2020 Apr; 39(4):e1900023. PubMed ID: 31648416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin B inhibitors: Further exploration of the nitroxoline core.
    Sosič I; Mitrović A; Ćurić H; Knez D; Brodnik Žugelj H; Štefane B; Kos J; Gobec S
    Bioorg Med Chem Lett; 2018 Apr; 28(7):1239-1247. PubMed ID: 29503024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding mode of an E-64 analog to the active site of cathepsin B.
    Feng MH; Chan SL; Xiang Y; Huber CP; Lim C
    Protein Eng; 1996 Nov; 9(11):977-86. PubMed ID: 8961350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel covalent proteasome inhibitors through a combination of pharmacophore screening, covalent docking, and molecular dynamics simulations.
    Li A; Sun H; Du L; Wu X; Cao J; You Q; Li Y
    J Mol Model; 2014 Nov; 20(11):2515. PubMed ID: 25394401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular dynamics to enhance structure-based virtual screening on cathepsin B.
    Ogrizek M; Turk S; Lešnik S; Sosič I; Hodošček M; Mirković B; Kos J; Janežič D; Gobec S; Konc J
    J Comput Aided Mol Des; 2015 Aug; 29(8):707-12. PubMed ID: 25947277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand- and structure-based in silico studies to identify kinesin spindle protein (KSP) inhibitors as potential anticancer agents.
    Balakumar C; Ramesh M; Tham CL; Khathi SP; Kozielski F; Srinivasulu C; Hampannavar GA; Sayyad N; Soliman ME; Karpoormath R
    J Biomol Struct Dyn; 2018 Nov; 36(14):3687-3704. PubMed ID: 29064326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azapeptides structurally based upon inhibitory sites of cystatins as potent and selective inhibitors of cysteine proteases.
    Wieczerzak E; Drabik P; Łankiewicz L; Ołdziej S; Grzonka Z; Abrahamson M; Grubb A; Brömme D
    J Med Chem; 2002 Sep; 45(19):4202-11. PubMed ID: 12213061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the cathepsin cysteine proteases B and K by square-planar cycloaurated gold(III) compounds and investigation of their anti-cancer activity.
    Zhu Y; Cameron BR; Mosi R; Anastassov V; Cox J; Qin L; Santucci Z; Metz M; Skerlj RT; Fricker SP
    J Inorg Biochem; 2011 May; 105(5):754-62. PubMed ID: 21481817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses.
    Arodola OA; Soliman ME
    Drug Des Devel Ther; 2015; 9():6055-65. PubMed ID: 26622167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.
    Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC
    Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
    Kumar R; Garg P; Bharatam PV
    J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Cathepsin B in Cancer Progression: A Potential Target for Coordination Compounds.
    Akinyemi AO; Pereira GBS; Rocha FV
    Mini Rev Med Chem; 2021; 21(13):1612-1624. PubMed ID: 33583372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theoretical insight into the mechanism for the inhibition of the cysteine protease cathepsin B by 1,2,4-thiadiazole derivatives.
    Vega-Teijido MA; El Chamy Maluf S; Bonturi CR; Sambrano JR; Ventura ON
    J Mol Model; 2014 Jun; 20(6):2254. PubMed ID: 24881000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WIDOCK: a reactive docking protocol for virtual screening of covalent inhibitors.
    Scarpino A; Petri L; Knez D; Imre T; Ábrányi-Balogh P; Ferenczy GG; Gobec S; Keserű GM
    J Comput Aided Mol Des; 2021 Feb; 35(2):223-244. PubMed ID: 33458809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of cathepsin inhibitors and structure-based design of cathepsin B-specific inhibitor.
    Tomoo K
    Curr Top Med Chem; 2010; 10(7):696-707. PubMed ID: 20337581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.